Abstract. Malignant gliomas are a group of aggressive neoplasms among human cancers. The curative effects of current treatments are finite for improving the prognosis of patients. Hyperthermia (HT) is an effective treatment for cancers; however, the effects of HT with different temperatures in treatment of MG and relevant mechanisms remain unclear. MTT assay and Annexin V-fluorescein isothiocyanate/propidium iodide staining were used for investigating the proliferation and apoptosis of C6 cells, respectively. Western blotting was applied to detect the expression of proteins. Ultrasonography was employed to evaluate the tumor formation rate, growth rate, angiogenesis rate and degree of hardness of tumors in vivo. The authors certified that HT with 42-46˚C x 1 h, 1 t could inhibit proliferation, promote apoptosis, reduce tumor formation rate, growth rate, angiogenesis rate, degree of hardness of tumors, ischemic tolerance and anoxic tolerance, and have synergy with temozolomide in C6 cells. Long-term HT (43˚C x 1 h, 1 t/5 d, 90 d) did not cut down the sensitivity of C6 cells to HT, and sustainably inhibited the proliferation of C6 cells. Furthermore, the authors proved HT produced these effects primarily through inhibition of the EGFR/STAT3/HIF-1A/VEGF-A pathway.
Introduction
Malignant gliomas (MGs) are a group of heterogeneous primary central nervous system (CNS) tumors arising from glial cells. MGs account for the majority of malignant primary CNS tumors, and are associated with high morbidity and mortality (1) . In spite of current approaches in their therapy, including surgical resection, radiotherapy and chemotherapy, the prognosis of these patients remains poor. The median overall survival length after first-line therapy does not exceed 15 months (2) . Thus, more recently, various minimally invasive treatments are under study, including hyperthermia (HT), which is a therapeutic procedure that increases the temperature in body tissues and maintains a period of time, for inhibiting proliferation and promoting the apoptosis of cancer cells (3) . In randomized control studies, HT has been reported as an effective therapy for many cancers, including gastric cancer (4), breast cancer (5) and liver cancer (6) . Previous research has demonstrated that HT could inhibit proliferation or promote apoptosis in human MGs. Cha et al (7) demonstrated HT suppressed glioma cell proliferation and mobility through the induction of E2F1-mediated apoptosis. Wang et al (3) proved HT promoted apoptosis and suppressed invasion through TNF-A/P38/NF-κB pathway in C6 cells. Sun et al (8) certified MGs in the HT group exhibited growth retardation or growth termination in a clinical study with 30 pathologically diagnosed patients with grade III-IV primary or recurrent MGs. Moreover, HT has synergistic effects when combined with chemotherapeutic agents in treating cancers. However, there is no systematic research concerning the effects of HT with different doses and relevant mechanisms in MGs.
The epidermal growth factor receptor (EGFR) and signal transducers and activators of transcription (STATs) are commonly expressed and activated in many malignancies, including MGs. EGFR is one of four homologous transmembrane proteins that regulate various signaling pathways in proliferation, apoptosis and inflammation through the activation of phospholipases (9) . STATs comprise a family of seven structurally and functionally related proteins. Aberrant activation of STAT3 is commonly observed in tumors and is strongly associated with tumor development and Hyperthermia with different temperatures inhibits proliferation and promotes apoptosis through the EGFR/STAT3 pathway in C6 rat glioma cells YAO-DONG CHEN  1 , YU ZHANG  1 , TIAN-XIU DONG  1 , YU-TONG XU  1 ,   WEI ZHANG  1 , TING-TING AN  1 , PENG-FEI LIU  2 and XIU-HUA YANG   1 progression (10) . STAT proteins participate in tumorigenesis through upregulation of genes encoding apoptosis inhibitors myeloid cell leukemia sequence 1, BCL2-like 1 and cell cycle regulators (cyclin D1/D2, MYC) (11) . STAT3 is also involved in tumor progression through inducing angiogenic factors, such as vascular endothelial growth factor (VEGF) (12) . Moreover, previous studies have revealed a critical role of STAT3 in maintaining EGFR-mediated cancer cell proliferation (13, 14) . EGFR likely activates STAT in a manner distinctive from other mechanisms of STAT activation (9) . In view of the important role of EGFR/STAT3 signaling in tumor development and progression, the methods to inhibit EGFR in conjunction with oncogenic STATs may represent a novel and attractive therapeutic strategy for cancers characterized by upregulation of EGFR signaling (15) . In the current study, the authors demonstrated the intense effects of HT on inducing apoptosis in C6 cells, which was associated with EGFR/STAT3 signaling. MTT. Standard microplate MTT assays were used to examine the growth rate of C6 cells, which were treated at 42-46˚C x 1 h. Briefly, C6 cells with/without pre-HT were plated at a density of 3x10 3 cells per well in 96-well plates. At the end of 24, 72, 96 and 120 h of incubation, cells were stained by 0.5 mg/ml MTT (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for a further 4 h at 37˚C in an incubator. The medium was removed afterwards and the intracellular formazan crystals were dissolved by adding 100 µl dimethylsulfoxide/well. Absorbance was read at 490 nm on a microplate reader (ELx808, BioTek Instruments, Inc., Winooski, VT, USA). The experiments were repeated three times.
Materials and methods

Cell
Cell apoptosis assay. The C6 cells were plated in culture flasks and, after 24 h, cells were exposed to HT with 43-45˚C x 1 h, 1 t, then the cells were maintained for 48 h. To determine the extent of spontaneous apoptosis, 1x10 5 Ultrasound. To evaluate the tumor formation rate, growth rate, angiogenesis rate and degree of hardness of tumors in vivo, the authors used B-mode ultrasonography, color Doppler flow imaging (CDFI) and ultrasonic elastosonography (USE) of Philips iU Elite Ultrasound System (Philips Healthcare, Amsterdam, The Netherlands), respectively (17) . These detections were observed by an experienced ultrasound doctor, who was blind to the study.
H&E staining for pathological examination. The tumor tissues were fixed in formalin, followed by routine embedding with paraffin and sectioning. The sections were then subjected to deparaffinization and H&E staining. An experienced pathologist who was blind to the study was asked to perform the pathological examination. 
Results
The reference standard of HT in C6 cells. To explore the effects of HT with different doses in C6 cells, the authors adopted HT with 42-46˚C x 1 h, 1 t and continuously observed the status of C6 cells before and after (0, 12, 24, 48, 72, 96 and 120 h) HT. A reference standard of HT was established with different doses in C6 cells. In addition, the results indicated that 42-46˚C x 1 h, 1 time could inhibit proliferation and promote apoptosis or necrosis in a temperature dependent manner in C6 cells (Fig. 1) .
HT with different doses inhibited proliferation and promoted apoptosis in C6 cells. To further testify the effects of HT with different doses on inhibiting proliferation and promoting apoptosis in C6 cells, the authors applied an MTT assay and Annexin V-FITC/PI staining, respectively. The results indicated that HT with 42-44˚C x 1 h, 1 t could inhibit the proliferation of glioma cells in a temperature dependent manner ( Fig. 2A) . When the temperature reaches 45˚C, a low number of living cells adhered to the bottom of culture flasks, thus proliferation was not detected. In addition, the authors proved that HT with 43-45˚C x 1 h, 1 time primarily induced apoptosis in a temperature dependent manner (Fig. 2B and C) . to HT is similar to C6 cells (Fig. 3A) . Following HT (24, 48, 72, 96 and 120 h) with 43˚C x 1 h, 1 t in C6-90d cells and C6 cells, it was demonstrated that the proliferation of C6-90d cells was reduced compared to C6 cells (Fig. 3B) . In addition, the authors discovered the increase of apoptosis of C6-90d cells was indistinctive and without statistical significance compared to C6 cells following HT with 43˚C x 1 h ( Fig. 2B and D) .
HT (44˚C x 1 h, 1 t) had synergy with TMZ.
Following HT (24 h) with 441˚C x h, 1 t, the authors replaced the original culture solution with culture solution containing TMZ (1 mM). At 72 h later, pictures were taken, and the MTT assay was conducted for every group, proving that HT (44˚C x 1 h, 1 t) had synergy with TMZ (Fig. 4) .
HT (44˚C x 1 h, 1 t) in vivo.
For animal experiments, 15 rat models were established and, after 15 d, the authors used B-mode ultrasonography, CDFI and USE to evaluate the tumor formation rate, growth rate, angiogenesis rate and degree of hardness of tumor in vivo, respectively, and found that the aforementioned indexes of 44˚C x 1 h, 1 time group were reduced compared with the control group (Table I; Fig. 5A ). The pathological results were consistent with the ultrasonography results ( Fig. 5B and C) . Additionally, the expression of vital factor of angiogenesis VEGF-A was reduced after HT (Fig. 5D) .
Moreover, in the center of the tumor of the 44˚C x 1 h, 1 t group, the authors discovered necrosis, even the tumors were small. A hypothesis was established suggesting that HT augmented the sensibility of C6 to ischemia and hypoxia, hence the authors designed an ischemia model and a 96-well plate gradient hypoxia model (Fig. 5G) to certify the hypothesis, and this produced positive results (Fig. 5E and F) . Following this, human umbilical vein endothelial cells (HUVECs) and human renal tubular epithelial cells (HK2) were used to examine the 96-well plate gradient hypoxia model, and proved it was effective ( Fig. 5H and I ).
Mechanisms of HT with different doses.
To determine whether it was C6 cells rather than other cells in the tumor microenvironment that cut down the expression of VEGF-A, the authors tested the expression of VEGF-A following HT at different temperatures in C6 cells, and found that they were reduced in a temperature dependent manner. Following this the EGFR/STAT3/HIF-1A pathway which is upstream of VEGF-A, was investigated (18) (19) (20) , and found that the expression and activation of these genes were reduced in the same manner (Fig. 6A) .
Apoptosis related genes Bax and Bcl-2, both downstream of STAT3, can lead to mitochondrion mediated apoptosis (21) , and the present study detected an increase in Bax and decrease in Bcl-2 after HT. In addition, the expression of MGMT, which is related to the drug resistance of MGs to TMZ, was in accordance with results of STAT3 (Fig. 6B) .
Discussion
HT is one of the newest therapies for tumors in recent years, however there has been no systematic research conducted concerning using HT at different time periods. Therefore, we conducted this study. The authors carried out HT at conditions of 42-46˚C x 1 h, 1 t, and continuously observed the status of C6 cells before and after (0,12, 24, 48, 72, 96 and 120 h) HT, and found that the scope of temperatures of HT in C6 cells were narrow, just 42-46˚C. HT could inhibit proliferation and promote apoptosis in this scope of temperatures in a temperature dependent manner in C6 cells. To explore the effects of long-term HT, long-term HT was adopted with 43˚C x 1 h, 1 t/5 d, 90 d, and obtained a new cell line named C6-90d. Sensitivity of C6-90d to HT was similar to C6 cells. HT with 43˚C x 1 h, 1 t could inhibit the proliferation of C6-90d cells, but could not significantly promote apoptosis compared to C6 cells. In order to facilitate communication, the authors recommend the above methods to represent the dose of HT. Wang et al (3) have demonstrated that HT could inhibit the migration and invasion of C6 cells, so similar studies were not conducted. TMZ is one of the clinical standard chemotherapy drugs for glioma, but drug resistance has been demonstrated to always interfere with the efficacy of TMZ (22) . The present study testified that HT had synergy with TMZ.
In subcutaneous tumor models of glioma, the authors found the tumor formation rate, growth rate, angiogenesis rate and degree of hardness of tumor were reduced following HT at 44˚C x 1 h, 1 t. The ultrasonography results were consistent with the pathological results. Then it was detected that the vital factor of angiogenesis VEGF-A was reduced. To determine whether it was C6 cells rather than other cells in the tumor microenvironment that cut down the expression of VEGF-A, the authors tested the expression of VEGF-A after HT with different dose in C6 cells, and found that they were reduced in a temperature dependent manner. Then the authors detected Table I . Tumor formation rate of Wistar rats.
Total (n) 13 2 15 Tumorigenesis (+), non-tumorigenesis (-). The tumor formation rate of 44˚C x 1 h, 1 t group was reduced compared to control group, 33% vs. 87%, P<0.01.
the EGFR/STAT3/HIF-1A pathway, upstream of VEGF-A, and discovered that the expression and activation of these genes are reduced in the same manner. According to the results of the present study, the C6-90d group is the most obvious group. Because STAT3 plays an important role in the occurrence and progress of tumor (23), it can promote the proliferation, migration, invasion and resistance to TMZ of glioma (24) .
Therefore, the authors believe that HT can suppress the proliferation, migration, invasion, tumorigenic rate, growth rate, angiogenesis rate and degree of hardness of tumors through inhibiting the EGFR/STAT3/HIF-1A/VEGF-A pathway. Reduced tumor angiogenesis leaded to ischemia and hypoxia after HT, plus HT augmented the sensitivity of C6 cells to ischemia and hypoxia, which might be attributed to the vast energy and organic ingredients for cell repair following HT or the reduction of glioma stem cells caused by HT (25) . Forming a benign positive feedback mechanism that reduced tumor angiogenesis leads to ischemia and hypoxia after HT. The C6 cells that could not tolerate ischemia and hypoxia underwent apoptosis, further reducing the total expression of VEGF-A. For detecting the tolerance of C6 cells to hypoxia after HT, the authors designed a 96-well plate gradient hypoxia model, this model creates graded hypoxia through four mechanisms: First, the concentration of O 2 is gradually reduced from 12 side orientation to 1 side, because O 2 is gradually consumed; second, the space for accommodating O 2 gradually shrink from 12 side orientation to 1 side. third, water vapor pressure is higher on 1 side; fourth, CO 2 pressure is higher on 1 side because CO 2 discharged by cell respiration cannot be eliminated. All of them reduce the amount and speed of entering of O 2 . It can be used to roughly determine the hypoxia tolerance of cells, because it can simulate the gradient hypoxia and change of CO 2 content of perivascular tissue. The authors proved its effect using HUVECs and HK2.
Hou et al (26) indicated that HT induced apoptosis of osteosarcoma cells was mediated by mitochondrial apoptosis pathway. STAT3, as a multifunctional gene, plays crucial regulatory roles in many aspects. Wang et al (27) certified that the JAK2/STAT3 pathway could increase the expression of Bax and decrease the expression of Bcl-2, then induced mitochondria-mediated apoptosis. Therefore, the authors tested the expression of Bax and Bcl-2, and found that HT increased expression of Bax and decreased expression of Bcl-2. The EGFR/STAT3/HIF-1A/VEGF-A pathway of the C6-90d group was significantly inhibited compared to 45˚C x 1 h, 1 t group, but the apoptosis of the C6-90d group did not increased correspondingly. Hence, the authors assumed that there were other mechanisms involved in HT with 45˚C 1 h, 1 t induced apoptosis. The high expression of MGMT is the primary reason of drug resistance of MGs to TMZ. Kohsaka et al (28) proved inhibition of STAT3 could reduce the expression of MGMT. The expression of MGMT was reduced after HT. The synergy of HT and TMZ is attributed to the inhibition of the EGFR/STAT3/MGMT pathway.
In conclusion, these experiments explored the curative effects of HT at different time periods, certified HT could inhibit proliferation, promote apoptosis, reduce tumor formation rate, growth rate, angiogenesis rate, degree of hardness of tumors, ischemic tolerance and anoxic tolerance, and have synergy with TMZ in C6 cells. Long-term HT (43˚C x 1 h, 1 t/5 d, 90 d) did not impair the sensitivity of C6 cells to HT, and sustainably inhibited the proliferation of C6 cells. The authors further proved HT produced these effects mainly through inhibition of the EGFR/STAT3/ HIF-1A/VEGF-A pathway. However, the mechanisms underlying how HT at 45˚C x 1 h, 1 t led to increased apoptosis are not completely clear, and will be focused on in future research of the authors.
However, due to the current technical conditions, HT cannot be maintained accurately at higher temperatures (45˚C), as it would damage normal brain tissue (29) . However, with the development of nanotechnology-dependent precise HT (30) , improvement of treatment strategies, and adoption of auxiliary measures, HT will become an important member of combined treatments using MGs in the near future. 
